Amgen, J&J Revise Labels For Aranesp, Epogen, Procrit

Amgen says it will present new data to CMS in effort to persuade agency to modify its National Coverage Decision on ESAs.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet